Clinical Trial Update: Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating NCX-4240 eye drops containing iota-carrageenan for adenoviral conjunctivitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoviral Conjunctivitis

Drugs mentioned

• NCX-4240 eye drops (iota-carrageenan)

Snippet

Sponsor: NicOx | Conditions: Adenoviral Conjunctivitis | Phase 2 | Status: WITHDRAWN